Monday, 16 September 2019

Intec Pharma acknowledged with patent

08 January 2018 | Regulatory

For Accordion Pill, Intec Pharma got Patent in Canada

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology.

The company announced that the Canadian Intellectual Property Office has issued a Certificate of Grant of a Canadian patent No. 2,721,493.

The patent, entitled "Carbidopa/Levodopa Gastroretentive Drug Delivery," broadly covers the Accordion Pill.

It contains certain drugs including the combination of Carbidopa and Levodopa, which provides patent protection through April 2029.

The patent belongs to the Company's IN-7 patent family, which already includes patents granted in the U.S., Europe, China, Japan, South Korea, Hong Kong, South Africa, and Israel.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls